Drug Channels

APRIL 1, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription.

Pharmacy 98

Pharmacy Branding Sales Drugs 98

Pharmaceutical Technology

JULY 20, 2022

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Pharmacy 278

Pharmacy Licensing Licensing Drugs 278

Fierce Pharma

JUNE 20, 2023

Three weeks after the FDA warned that some pharmacies are making unauthorized versio | Novo Nordisk filed five lawsuits in four states on Tuesday, charging health spas, clinics and pharmacies with false advertising, trademark infringement and unlawful sales of compounded versions of diabetes and weight loss drugs Ozempic and Wegovy.

Pharmacy 124

Pharmacy Sales Drugs 124

Drug Channels

OCTOBER 27, 2023

Under the program, the out-of-pocket cost for Sanofi's Lantus will be capped at $35 at any pharmacy that accepts GoodRx. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This program will increase affordabiliy and broaden access for people living with diabetes.

Pharmacy 98

Pharmacy Sales Drugs 98

Drug Channels

APRIL 15, 2025

Whether you're building trust with customers, launching new products, or guiding internal teams, understanding the economic forces that shape drug distribution, reimbursement, and pricing is essential. Understand reimbursement dynamics, cost estimation methods, and how profitability varies across drug types and dispensing models.

Pharmacy 52

Pharmacy Licensing Licensing Drugs 52

XTalks

MARCH 17, 2025

billion, primarily linked to initiating Phase III trials for petrelintide as a stand-alone therapy, with sales-based milestones that could push the total value to $5.3 Under the deal, Zealand Pharma will receive an upfront cash payment of $1.65 billion $1.4 billion at closing and an additional $250 million over the first two anniversaries.

Hormones 59

Hormones Drugs Sales Insulin 59

Pharmaceutical Technology

JULY 15, 2022

CivicaRx is a non-profit generic drug company producing affordable insulin biosimilars in collaboration with the Juvenile Diabetes Research Foundation (JDRF). Making low-cost insulin widely available will benefit anyone who struggles to afford this drug,” he adds. In-house manufacturing the norm. Industry split over the pricing issues.

Insulin 328

Insulin Manufacturing Contract Manufacturing Production 328

Pharmacy Checkers

APRIL 3, 2020

When I read fancy-looking international reports that address the problem of counterfeit drugs, too seldom is our work recognized in verifying international online pharmacies in a manner that saves the lives of consumers looking online for affordable medicine. percent – or $461 billion— of the world drug market in 2013.”

Pharmacy 60

Pharmacy Drugs Medicine Sales 60

Pharmaceutical Commerce

APRIL 28, 2023

“Deep learning” IT tools were used to calculate sales volumes and drug class.

Sales 64

Sales Pharmacy Drugs 64

Pharmacy Checkers

FEBRUARY 5, 2021

The Rand Corporation has released an impressive study showing that brand name drugs cost far more in the United States than in other countries – on average 344% more. For those of you looking for a methodologically strong analysis of international drug prices and a history of related studies, this is the report for you.

Branding 97

Branding Drugs Sales Generic Drugs 97

pharmaphorum

JUNE 8, 2022

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC). — FTC (@FTC) June 7, 2022. — FTC (@FTC) June 7, 2022.

Pharmacy 64

Pharmacy Medicine Drugs Manufacturing 64

Pharmacy Checkers

DECEMBER 5, 2019

A new Chinese law (in effect as of December 1, 2019) makes third-party online platform medicine sales legal, appropriately ends a draconian definition of counterfeit drugs, and effectively decriminalizes personal drug importation, but with a lot of gray! Decriminalizing Personal Drug Importation and Redefining “Counterfeit”.

Sales 64

Sales Medicine Pharmacy Drugs 64

XTalks

DECEMBER 18, 2024

Neurocrine Biosciences Crenessity (crinecerfont) has been given the green light by the US Food and Drug Administration (FDA) as a new treatment for congenital adrenal hyperplasia (CAH). Crenessity marks the third approved drug for Neurocrine. billion in revenue by 2024.

Genetics 116

Genetics Hormones Trials Drugs 116

Druggist

MARCH 23, 2021

Ibuprofen is one of the most common drugs purchased over the counter in the UK. In recent months, ibuprofen’s price went up significantly, with many shops and pharmacies being out of stock of ‘cheap’ ibuprofen. Today I will review ibuprofen alternative drugs. Other alternative drugs to ibuprofen.

Drugs 92

Drugs Pharmacy Containment Branding 92

XTalks

NOVEMBER 7, 2024

Galderma’s doxycycline drug Oracea (doxycycline 40 mg capsules) is the current standard-of-care treatment for rosacea. Maraoui said the company’s dermatology-focused sales force is “now preparing for a successful launch and to establish Emrosi as a new standard of care in the treatment of rosacea.”

FDA Approval 105

FDA Approval Dermatology Bacteria Clinical Trials 105

STAT News

MARCH 29, 2023

British Columbia plans to limit sales of the popular diabetes drug Ozempic to Canadian residents in response to a wave of Americans flocking to local pharmacies in search of the drug, potentially straining supplies in the province. residents, according to a Tuesday release from the province.

Pharmacy 116

Pharmacy Sales Regulation Drugs 116

XTalks

JANUARY 24, 2022

Gilead Sciences has been seizing counterfeit versions of its HIV drugs Biktarvy and Descovy since last year and is now suing distributors who have been behind selling the illicit medications. The counterfeit drugs were being sold across several states in the US over the past two years. While Biktarvy brought in $7.3

Drugs 98

Drugs Pharmacy Production Containment 98

XTalks

JANUARY 29, 2025

Eli Lilly launched a 75-second TV commercial called Change in November 2024 to promote the companys GLP-1 obesity drug Zepbound (tirzepatide). This month, Zepbound won FDA approval for obstructive sleep apnea (OSA) , making it the first approved drug for the condition. Late last year, Zepbound brought in $1.26

FDA Approval 71

FDA Approval Drugs Hormones Marketing 71

XTalks

AUGUST 22, 2024

After a nearly two-year-long shortage, the US Food and Drug Administration (FDA) announced earlier this month that Eli Lilly’s GLP-1 diabetes drug Mounjaro (tirzepatide) is back on shelves along with weight loss version Zepbound. The drugs have been on the FDA’s drug shortages list since 2022. mg, 1 mg, 1.7 mg and 2.4

Drugs 111

Drugs Manufacturing Production Pharmacy 111

pharmaphorum

JANUARY 20, 2022

According to the company, the defendants reportedly sold 85,247 bottles of medicine with counterfeit Gilead labelling to pharmacies over a two-year period, using falsified supply chain documentation to conceal their origin. This works to ensure the safety and efficacy of the drugs received by patients.

Drugs 111

Drugs Medicine Containment Branding 111

pharmaphorum

JANUARY 27, 2023

Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients out of “at least $100 million.” The post J&J copay lawsuit against drug benefit firm gets green light appeared first on.

Drugs 105

Drugs Pharmacy Medicine Manufacturing 105

XTalks

JULY 19, 2024

Compounded GLP-1 medications, created by specialized pharmacies under a special US Food and Drug Administration (FDA) allowance due to ongoing shortage, have become increasingly popular for weight loss. The report also shows a rapid rise in compounding pharmacies.

Pharmacy 104

Pharmacy Drugs Production Sales 104

Drug Channels

OCTOBER 25, 2021

By reader request, we present below a channel flow chart illustrating the buy-and-bill process for provider-administered drugs. Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. The video is excerpted from my recent Drug Channels Update: Buy-and-Bill Trends video webinar.

Drugs 97

Drugs Pharmacy Branding Sales 97

Drug Channels

APRIL 21, 2022

By reader request, we present below a channel flow chart illustrating the buy-and-bill process for provider-administered drugs. Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. The video is excerpted from my recent Drug Channels Update: Buy-and-Bill Trends video webinar.

Drugs 98

Drugs Pharmacy Branding Sales 98

Pharmaceutical Technology

JANUARY 2, 2023

The characteristics of the clinical trial as well as other attributes related to the drug, regulations, and company play a fundamental role in ensuring the likelihood of transition that the drug moves from its current development stage to next. It is developed based on MyoKardia's drug discovery platform.

Drugs 100

Drugs Development Production Pharmacy 100

Drug Channels

OCTOBER 8, 2021

To learn more, please contact Trialcard at sales@trialcard.com or visit them in booth #416 at the upcoming Asembia Specialty Pharmacy Summit from October 26 to 29, 2021. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Read on for Bill’s and Eric’s insights.

Marketing 98

Marketing Pharmacy Sales Drugs 98

Pharmaceutical Technology

APRIL 24, 2023

Researchers may develop nanodrugs due to their smaller surface area to allows drugs to dissolve faster, or nanoparticles may encapsulate drugs, so they last longer in the body. Since then, the drug has been used off-label in breast cancer and other types of cancer. He says, “It gave a new lease [on] life to the field”.

Drug Delivery 147

Drug Delivery Vaccine Vaccination Research 147

FDA Law Blog

AUGUST 21, 2023

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). Regulated sellers must limit daily sales of SCLPs to 3.6

Pharmacy 52

Pharmacy Regulation Sales Production 52

pharmaphorum

AUGUST 18, 2022

.” Separately, the company also agreed in principle a deal with 34 US states to provide $450 million over a period of 10 years, to resolve allegations that the company boosted opioid sales using deceptive marketing practices. Pharmacy chains ordered to pay $650m.

Pharmacy 108

Pharmacy Marketing Sales Manufacturing 108

Pharmaceutical Technology

SEPTEMBER 5, 2022

Wholesale distributors are responsible for guaranteeing product quality and preventing the influx of counterfeited drugs. Wholesalers can be either full-line wholesalers, who purchase the complete product line of a company, or specialised companies, which purchase speciality drugs to sell to clinics and hospitals. GDP and GMP advisory.

Packaging 130

Packaging Packaging Compliance Manufacturing 130

XTalks

SEPTEMBER 21, 2023

Lilly is suing eight companies, accusing them of making and selling compounded versions of its diabetes drug Mounjaro (tirzepatide). However, like Ozempic, it also has weight loss effects, which has prompted many people to seek it off-label, resulting in some controversy and exacerbating shortages of the drugs.

Pharmacy 59

Pharmacy FDA Approval Drugs Containment 59

XTalks

SEPTEMBER 19, 2023

The US Food and Drug Administration (FDA) has issued warning letters to eight companies manufacturing or marketing unapproved eye products that violate federal law. The ophthalmic eye products in question include drugs that claim to treat diseases such as pink eye, glaucoma and cataracts, among others.

Production 105

Production Pharmacy Drugs Sales 105

pharmaphorum

JULY 22, 2022

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. ” The post Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe appeared first on.

Drugs 111

Drugs Marketing Pharmacy Branding 111

Pharmaceutical Technology

SEPTEMBER 8, 2022

Increasing drug failure rates and essential drug shortages have driven the growth of the compounding pharmacies market, which has a high growth potential, especially in emerging economies. It may provide access to discontinued drugs and allows for alternative compounded dosage forms. Test method development.

Marketing 100

Marketing Pharmacy Containment Sales 100

Pharmacy Checkers

APRIL 17, 2020

I only believe this to be the case if the exporting pharmacy requires a valid prescription. I don’t know if the FDA is more aggressive with rogue pharmacy actors than with legitimate pharmacies. Tens of millions more people are unemployed and among them will be people who purchased a prescription drug from another country.

Pharmacy 97

Pharmacy Packaging Packaging Drugs 97

Pharmaceutical Technology

JANUARY 6, 2023

In this most recent settlement, the drug company faced allegations of colluding with the generics company Par Pharmaceuticals to violate antitrust laws. Novartis has also been on the receiving end of litigation with the Greek health ministry, academic institutes, and more, engaging the drug company in other legal disputes.

Doctor 242

Doctor Doctors Drugs Sales 242

XTalks

JULY 10, 2023

With the remarkable success of its semaglutide products Wegovy and Ozempic for weight loss and type 2 diabetes, respectively (the latter also for weight loss through off-label prescribing), Novo Nordisk is cracking down on pharmacies making compounded versions of the glucagon-like peptide-1 (GLP-1) receptor agonist drugs.

Pharmacy 90

Pharmacy FDA Approval Licensing Licensing 90